Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINIK FOR MANUEL BEHANDLING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.0% 3.2% 2.4% 2.3% 2.8% 3.0% 16.1% 15.8%   Credit score (0-100)   71 57 63 63 59 56 11 12   Credit rating   A BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,325 1,351 1,295 1,506 1,437 1,339 0.0 0.0   EBITDA   610 215 216 323 214 173 0.0 0.0   EBIT   599 204 205 311 195 152 0.0 0.0   Pre-tax profit (PTP)   595.7 193.1 203.2 308.4 189.0 147.1 0.0 0.0   Net earnings   459.5 148.2 157.7 239.5 146.6 113.5 0.0 0.0   Pre-tax profit without non-rec. items   596 193 203 308 189 147 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   54.9 43.4 31.9 20.4 35.4 15.1 0.0 0.0   Shareholders equity total   747 406 453 580 612 608 361 361   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,152 596 718 755 743 813 361 361   Net Debt   -803 -321 -433 -469 -427 -523 -361 -361     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,325 1,351 1,295 1,506 1,437 1,339 0.0 0.0   Gross profit growth   -27.1% 1.9% -4.2% 16.3% -4.6% -6.8% -100.0% 0.0%   Employees   0 0 0 0 0 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,152 596 718 755 743 813 361 361   Balance sheet change%   -25.1% -48.2% 20.5% 5.0% -1.6% 9.4% -55.6% 0.0%   Added value   610.5 215.1 216.0 322.8 206.5 172.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -23 -23 -23 -23 -4 -41 -15 0   Net sales trend   -1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   45.2% 15.1% 15.8% 20.7% 13.6% 11.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   44.5% 23.3% 31.1% 42.3% 26.0% 19.6% 0.0% 0.0%   ROI %   64.0% 35.0% 47.1% 59.4% 32.2% 24.8% 0.0% 0.0%   ROE %   49.1% 25.7% 36.7% 46.4% 24.6% 18.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   64.9% 68.1% 63.1% 76.8% 82.6% 74.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -131.5% -149.1% -200.3% -145.3% -199.6% -302.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   2.4 2.4 2.2 3.7 4.9 3.3 0.0 0.0   Current Ratio   2.4 2.4 2.2 3.7 4.8 3.3 0.0 0.0   Cash and cash equivalent   802.6 320.7 432.7 469.0 427.3 522.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   579.8 252.0 304.6 448.3 458.7 461.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 86 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 86 0 0   EBIT / employee   0 0 0 0 0 76 0 0   Net earnings / employee   0 0 0 0 0 57 0 0